MedPath
NMPA Approval

Entecavir Oral Solution

国药准字H20203583

November 17, 2020

Drug Information

恩替卡韦口服溶液

口服溶液剂

0.005%(210ml:10.5mg)

化学药品

November 17, 2020

Company Information

Applicant Company

江苏省泰州市高港区通江东路2号

Manufacturing Company

江苏省泰州市高港区通江东路2号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

恩替卡韦口服溶液 - NMPA 批准文号 | MedPath